Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for ...
The key secondary end point of overall survival (OS) was met in the DREAMM-7 trial of belantamab mafodotin (Blenrep; GSK) for the treatment of patients with relapsed/refractory multiple myeloma (R/R ...
Patients in the belantamab mafodotin arm received 2.5 mg/kg of the agent administered intravenously ... as well as in combination with novel agents and established therapies. DREAMM-8 (NCT04484623) is ...
The MG HS is offered with a conventional 1.5-litre turbocharged petrol engine lower down in the range, but there’s also a plug-in hybrid version from launch, which boasts a very competitive ...
Is the MG HS a good car? The MG HS will appeal to drivers who like getting their money’s worth, or perhaps are on a tight budget but still want a practical SUV for their next family car.
Is the MG HS a good car? The MG HS will appeal to drivers who like getting their money’s worth, or perhaps are on a tight budget but still want a practical SUV for their next family car.
Five percent of patients on one of the moderately emetogenic trials received dexamethasone ... and dolasetron (<8 h), it is not surprising that greater efficacy was noted in the delayed period ...
This is claimed to accelerate the hybrid ZS from 0-100km/h in 8.7sec. Of more relevance is its fuel consumption, and while local figures have not yet been confirmed, its European WLTP claims are ...
We used intravenous propofol (10 mg every 5–10 minutes to a maximum ... was 8 ± 1.52 in propofol group and 8.11 ± 1.31 in dexamethasone group at presenting time (P > 0.05).
The claimed combined fuel consumption is 6.9L/100km, with a highway claim of 5.8L/100km and an urban claim of 8.9L/100km, and the engine requires at least 95 RON premium fuel. Hybrid and plug-in ...